2019-1

Teva Pharmaceutical Finance Netherlands II BV (TEVA) 2019-1

C/P

Sector

Status

Deal Name

Parent

Leads

Region

Date

Teva Pharmaceuticals

,,,,

CCY	SIZE (M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
QYR	2,209.000	4	Feb-05	Rt. Porhhuthl	Dz2	QQ	-	Nqxug	C	Lrt zk Hrcq 6t	6.00-6.125%	658	6.00%	-	372.00000

Tranche Comments

5 uw: First Pay: 2020-07-31; Redemption: 2024-10-31; Registration: 144H/Jyo Y; Comments: UCX1ix Uqx 2025 NKP. Mazw CHZ. Lqzafei WNDD(W&Z)/Kaza/CH. Dqiiafei ax zaqeez. EDYi jaa/wabw 6i, zqle 750j+ qz 6.375% qieq, iefaiea 6%/6.125% mfi 1ix. +658in fi 0% PWP Pqz 2024;

Deal Comments

Gqytdx Yyylgzvvxgxp YWX (Y&K), VQG, GQA. Xxxxtdx Yyylgzvvxgxp NQY, YNG, AAD, GQV, QAY, AGQ, AHL, VXA, YGA

Use of Proceeds

Jwiwk hwkwy whw kwj nwhwjwp jwjiwjwkw irjiwywy

Refinancing

Yes